Antonio Rinaldi

Portici, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

First Detection of RGNNV Betanodavirus Genotype in Dactylopterus volitans (Linnaeus, 1758) and Balistes capriscus (Gmelin, 1798).

First Detection of RGNNV Betanodavirus Genotype in Dactylopterus volitans (Linnaeus, 1758) and Balistes capriscus (Gmelin, 1798).

Journal: Journal of fish diseases

Published: April 07, 2025

Development of TaqMan real-time PCR and droplet digital PCR protocols for the detection of Candidatus Midichloria mitochondrii and evaluation of exposure among wildlife.

Development of TaqMan real-time PCR and droplet digital PCR protocols for the detection of Candidatus Midichloria mitochondrii and evaluation of exposure among wildlife.

Journal: Veterinary research communications

Published: March 11, 2025

Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis.

Unveiling the pathophysiology of restless legs syndrome through transcriptome analysis.

Journal: iScience

Published: November 05, 2023

A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?

A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?

Journal: The breast journal

Published: March 30, 2020

Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages.

Leptin Signaling Contributes to Aromatase Inhibitor Resistant Breast Cancer Cell Growth and Activation of Macrophages.

Journal: Biomolecules

Published: February 28, 2020

Small-bowel carcinomas associated with celiac disease: transcriptomic profiling shows predominance of microsatellite instability-immune and mesenchymal subtypes.

Small-bowel carcinomas associated with celiac disease: transcriptomic profiling shows predominance of microsatellite instability-immune and mesenchymal subtypes.

Journal: Virchows Archiv : an international journal of pathology

Published: June 24, 2019

Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802).

Bevacizumab in Combination With Either FOLFOX-4 or XELOX-2 in First-line Treatment of Patients With Metastatic Colorectal Cancer: A Multicenter Randomized Phase II Trial of the Gruppo Oncologico dell'Italia Meridionale (GOIM 2802).

Journal: Clinical colorectal cancer

Published: April 08, 2019

Identification of long non‑coding RNA expression patterns useful for molecular‑based classification of type I endometrial cancers.

Identification of long non‑coding RNA expression patterns useful for molecular‑based classification of type I endometrial cancers.

Journal: Oncology reports

Published: July 13, 2018

Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts.

Activation of Farnesoid X Receptor impairs the tumor-promoting function of breast cancer-associated fibroblasts.

Journal: Cancer letters

Published: May 02, 2018

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.

Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.

Journal: The oncologist

Published: December 22, 2017

iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data.

iSmaRT: a toolkit for a comprehensive analysis of small RNA-Seq data.

Journal: Bioinformatics (Oxford, England)

Published: October 24, 2017

RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.

RAS testing of liquid biopsy correlates with the outcome of metastatic colorectal cancer patients treated with first-line FOLFIRI plus cetuximab in the CAPRI-GOIM trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: September 27, 2017

Showing 1-12 of 22

Last Updated: 09/26/2026